Global Drug and Gene Delivery Devices Market to Reach $1.2 Trillion by 2030
The global market for Drug and Gene Delivery Devices estimated at US$635.1 Billion in the year 2022, is projected to reach a revised size of US$1.2 Trillion by 2030, growing at a CAGR of 8.6% over the analysis period 2022-2030. Oral, one of the segments analyzed in the report, is projected to record 8.3% CAGR and reach US$582.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Inhalation segment is readjusted to a revised 8.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $173 Billion, While China is Forecast to Grow at 13.3% CAGR
The Drug and Gene Delivery Devices market in the U.S. is estimated at US$173 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$290 Billion by the year 2030 trailing a CAGR of 13.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 7.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.Select Competitors (Total 36 Featured) -
- Bayer AG
- Becton, Dickinson and Company
- Dickinson
- Epeius Biotechnologies
- F. Hoffmann-La Roche Ltd.
- Human Stem Cells Institute
- Johnson and Johnson
- Novartis AG
- Pfizer, Inc.
- Shanghai Sunway Biotech Co., Ltd.
- SiBiono GeneTech Co
- Uniqure N.V
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Becton, Dickinson and Company
- Dickinson
- Epeius Biotechnologies
- F. Hoffmann-La Roche Ltd.
- Human Stem Cells Institute
- Johnson and Johnson
- Novartis AG
- Pfizer, Inc.
- Shanghai Sunway Biotech Co., Ltd.
- SiBiono GeneTech Co
- Uniqure N.V
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 92 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 635.1 Billion |
Forecasted Market Value ( USD | $ 1200 Billion |
Compound Annual Growth Rate | 8.3% |
Regions Covered | Global |